.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The ICON7 trial evaluated bevacizumab added to standard platinum-based chemotherapy and maintenance treatment in women with newly diagnosed epithelial ovarian cancer. The addition improved progression-free survival overall, with a larger effect in patients at high risk of progression. The study helped establish anti-angiogenic therapy as one component of advanced ovarian-cancer management. For gynecologic oncologists, the result illustrates how treatment intensity should be matched to disease-risk phenotype. Bevacizumab requires monitoring for hypertension, proteinuria, thrombotic complications, impaired wound healing and gastrointestinal toxicity. Its benefit must therefore be considered alongside surgical timing and overall patient fitness.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The ICON7 trial evaluated bevacizumab added to standard platinum-based chemotherapy and maintenance treatment in women with newly diagnosed epithelial ovarian cancer. The addition improved progression-free survival overall, with a larger effect in patients at high risk of progression. The study helped establish anti-angiogenic therapy as one component of advanced ovarian-cancer management. For gynecologic oncologists, the result illustrates how treatment intensity should be matched to disease-risk phenotype. Bevacizumab requires monitoring for hypertension, proteinuria, thrombotic complications, impaired wound healing and gastrointestinal toxicity. Its benefit must therefore be considered alongside surgical timing and overall patient fitness.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
Last week
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
